MetLife Shareholders Approve All Proposals; Say-on-Pay Gets 95% Support
MetLife, Inc. (NYSE: MET) filed a Form 8-K to report the results of its June 17, 2025 annual meeting of common shareholders.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
MetLife, Inc. (NYSE: MET) filed a Form 8-K to report the results of its June 17, 2025 annual meeting of common shareholders. Three routine governance items were submitted and all received majority support.
- Board elections: Shareholders re-elected all eleven directors for terms expiring at the 2026 annual meeting. Support levels ranged from 97.8 % for Christian Mumenthaler to 94.4 % for Denise M. Morrison. Total broker non-votes on director items were 41.7 million.
- Auditor ratification: Deloitte & Touche LLP was re-appointed as independent auditor for 2025, receiving 558.7 million “For” votes (approx. 93 %), with 38.9 million against and 0.5 million abstentions.
- Say-on-Pay (advisory): Compensation for named executive officers was approved with 528.3 million “For” votes (approx. 95 %), 26.3 million against, and 1.9 million abstentions; 41.7 million broker non-votes applied.
No other business, financial results, or strategic transactions were disclosed. The filing is strictly limited to Item 5.07, indicating normal-course corporate governance actions rather than material operational developments.
Positive
- Strong shareholder support for all eleven directors, with the lowest approval still around 94 %, indicates broad investor confidence in current board composition.
- Auditor ratification passed with 93 % support, suggesting continued confidence in financial reporting integrity.
- Say-on-Pay received 95 % approval, lowering the risk of compensation-related activism or reputational issues.
Negative
- A few directors (e.g., Denise M. Morrison 6 % against; R. Glenn Hubbard 5 % against) faced higher opposition than peers, hinting at pockets of shareholder concern, though still immaterial.
8-K Event Classification
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Were all MetLife (MET) director nominees elected in 2025?
Who is MetLife's independent auditor for fiscal year 2025?
Did the 8-K disclose any financial results or strategic transactions?
How many broker non-votes were recorded on director elections?
AI-generated analysis. How Rhea-AI works. Not financial advice.